Poxvirus early gene transcription machinery (vRNAP complex) (vRNAP)

The poxvirus early gene transcription machinery is a sophisticated, multi-protein complex essential for the initial stage of the poxvirus life cycle. Packaged within the viral core, this machinery enables the virus to transcribe its early genes in the host cell's cytoplasm immediately after entry, bypassing the need for the host's nuclear transcription apparatus (NIH, 2021; Wikipedia, 2024). The core component is a multi-subunit DNA-dependent RNA polymerase (vRNAP), which works in concert with specialized viral factors such as the Viral Early Transcription Factor (VETF), the Viral Capping Enzyme (VCE), and the Nucleoside Triphosphate Phosphohydrolase I (NPH-I) to produce functional, capped, and polyadenylated viral mRNAs (ResearchGate, 2021; ResearchGate, 2023). This independence from the host nucleus makes the machinery a highly specific and potent target for antiviral intervention (SUNY, 2010). Although no drugs targeting these specific components are currently approved, the machinery is a focus for drug discovery and repurposing efforts, particularly in response to outbreaks of Mpox and the ongoing threat of variola virus (NIH, 2023; MDPI, 2024). Potential therapeutic strategies include small molecules that disrupt the assembly of the pre-initiation complex or inhibit the catalytic activity of the viral polymerase (NIH, 2023; ResearchGate, 2023).

Other names

Poxvirus RNA polymerase complexVaccinia virus transcription systemPoxvirus transcription apparatusPoxvirus DNA-dependent RNA polymerase complexvRNAP complex

Inhibition of viral DNA-dependent RNA polymerase (vRNAP) activity, disruption of the pre-initiation complex (PIC) formation, or inhibition of mRNA capping/processing